CRL Operating Cash Flow (Statement)

Charles River Laboratories · Operating Cash Flow (Statement)

CRL logo

CRL Operating Cash Flow (Statement)

Latest reported$582.15M
CRL TTM Cash from Operations ($33.77M → $582.15M)
High-resolution chart · PNG

CRL operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Charles River Laboratories Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
582,148,000
607,026,000
737,646,000
749,488,000
787,454,000
776,386,000
734,577,000
796,158,000
749,816,000
704,403,000
683,898,000
697,712,000
625,041,000
626,393,000
619,640,000
614,141,000
656,084,000
693,200,000
760,799,000
669,920,000
672,498,000
648,214,000
546,575,000
588,873,000
567,420,000
534,667,000
480,936,000
440,232,000
401,629,000
396,584,000
441,140,000
425,083,000
366,832,000
342,124,000
316,265,000
305,979,000
315,940,000
293,825,000
298,319,000
286,417,000
305,414,000
313,472,000
286,358,000
283,968,000
262,981,000
234,188,000
251,051,000
213,835,000
213,891,000
204,964,000
207,139,000
209,530,000
203,341,000
212,597,000
207,900,000
215,428,000
202,890,000
209,205,000
205,283,000
200,833,000
170,166,000
161,909,000
169,013,000
163,582,000
201,542,000
216,388,000
225,044,000
247,866,000
261,710,000
286,305,000
279,949,000
310,805,000
318,554,000
278,518,000
284,248,000
225,164,000
194,954,000
200,533,000
164,370,000
193,183,000
214,553,000
202,842,000
236,702,000
225,798,000
199,432,000
193,158,000
184,827,000
149,458,000
142,659,000
140,617,000
123,766,000
129,140,000
129,367,000
135,249,000
133,659,000
125,092,000
106,506,000
70,884,000
71,298,000
48,116,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.